Arsb Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The ARSB gene (Arylsulfatase B) encodes a lysosomal hydrolase enzyme that catalyzes the removal of sulfate groups from glycosaminoglycans (GAGs), particularly dermatan sulfate and chondroitin sulfate. This gene is essential for the degradation of these complex carbohydrates within lysosomes.
Function
...
ARSB Gene
Introduction
Arsb Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The ARSB gene (Arylsulfatase B) encodes a lysosomal hydrolase enzyme that catalyzes the removal of sulfate groups from glycosaminoglycans (GAGs), particularly dermatan sulfate and chondroitin sulfate. This gene is essential for the degradation of these complex carbohydrates within lysosomes.
Function
Arylsulfatase B is a member of the sulfatase family of enzymes. The enzyme hydrolyzes the sulfate ester bond at the non-reducing end of dermatan sulfate and chondroitin sulfate, playing a critical role in the lysosomal degradation pathway for glycosaminoglycans.
Enzymatic Activity
Catalyzes hydrolysis of sulfate groups from GAGs
Requires a unique post-translational modification (formylglycine cofactor)
Optimal activity in acidic lysosomal environment (pH 5.0-5.5)
Homodimeric structure with each subunit approximately 56 kDa
Role in Cellular Processes
Lysosomal Function: Essential for normal catabolism of dermatan sulfate and chondroitin sulfate
Proteoglycan Turnover: Regulates the degradation and recycling of proteoglycans in the extracellular matrix
Also known as Maroteaux-Lamy syndrome, MPS VI is caused by autosomal recessive mutations in the ARSB gene, resulting in deficient or absent arylsulfatase B activity.
Clinical Features:
Coarse facial features
Short stature
Joint stiffness and contractures
Dysostosis multiplex
Corneal clouding
Hearing loss
Valvular heart disease
Neurological involvement in some patients
Inheritance Pattern: Autosomal recessive
Neurological Involvement in MPS VI
While MPS VI is primarily a systemic disorder, neurological manifestations can include:
Delayed neurodevelopment in severe cases
Hydrocephalus
Spinal cord compression from atlantoaxial subluxation
Carpal tunnel syndrome affecting hand function
Expression
Brain Expression
ARSB is expressed in various tissues including brain
Higher expression in liver and skeletal muscle
Lysosomal enzymes generally expressed in [neurons](/entities/neurons) and glia
Expression pattern consistent with role in cellular waste removal
Allen Brain Atlas
Expression data from the Allen Brain Atlas indicates moderate expression across multiple brain regions, with particular enrichment in cells with high lysosomal activity.
Therapeutic Implications
Enzyme Replacement Therapy
Galsulfase (Naglazyme®) is an FDA-approved recombinant human arylsulfatase B
Approved for treatment of MPS VI
Does not cross the [blood-brain barrier](/entities/blood-brain-barrier), limiting CNS effects
Gene Therapy Approaches
AAV-mediated gene delivery being explored
Potential for treating neurological manifestations
Key Publications
Litjens T, et al. (1996). "Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS VI patients." Am J Hum Hum Genet. PMID: 8659546(https://pubmed.ncbi.nlm.nih.gov/8659546/)
Karageorgos L, et al. (2007). "Mutational analysis of 11 patients with mucopolysaccharidosis type VI." Clin Genet. PMID: 17250665(https://pubmed.ncbi.nlm.nih.gov/17250665/)
Harmatz P, et al. (2018). "Long-term outcomes in mucopolysaccharidosis type VI: 10-year results of the RhGUS enzyme replacement therapy trial." Mol Genet Metab. PMID: 29428225(https://pubmed.ncbi.nlm.nih.gov/29428225/)
See Also
[Mucopolysaccharidosis Type VI](/diseases/mucopolysaccharidosis-type-vi)
The study of Arsb Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.